Global Generic Drugs Market Growth (Status and Outlook) 2024-2030

2024

Global Generic Drugs Market Growth (Status and Outlook) 2024-2030

Name: Global Generic Drugs Market Growth (Status and Outlook) 2024-2030
Creator: Bonafide Research
License: https://www.bonafideresearch.com/license_information

Generic Drugs market expands from US$306.65 billion in 2023 to US$546.69 billion by 2030, with an 8.6% CAGR, due to increasing demand in the downstream market.

Bonafide Trust
04-01-2024
Pages : 152
Figures : 79
Tables : 151
Region : Global
Category : Lifescience
Pharmaceutical

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

Market Insights

According to Publisher’s latest study, the global Generic Drugs market size was valued at US$ 306650 million in 2023. With growing demand in downstream market, the Generic Drugs is forecast to a readjusted size of US$ 546690 million by 2030 with a CAGR of 8.6% during review period.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The research report highlights the growth potential of the global Generic Drugs market. Generic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Generic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Generic Drugs market.

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Research Consultant

Key Features:

The report on Generic Drugs market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Generic Drugs market. It may include historical data, market segmentation by Type (e.g., Oral, Injection), and regional breakdowns.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Generic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Generic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Generic Drugs industry. This include advancements in Generic Drugs technology, Generic Drugs new entrants, Generic Drugs new investment, and other innovations that are shaping the future of Generic Drugs.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Generic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Generic Drugs product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Generic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Generic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Generic Drugs market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Generic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Generic Drugs market.

Market Segmentation:

Generic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by Type:

a. Oral: Oral generic drugs are administered through the mouth and are absorbed through the gastrointestinal tract. They include tablets, capsules, syrups, and solutions. Oral administration is convenient and commonly used for chronic conditions where long-term medication is required.

b. Injection: Injectable generic drugs are administered directly into the body through various routes such as intravenous (IV), intramuscular (IM), or subcutaneous (SC) injections. They offer rapid and precise drug delivery and are often used for critical or acute conditions where immediate effect is required.

c. Other: This segment includes alternative methods of drug administration, such as inhalation (e.g., inhalers for respiratory conditions), topical application (e.g., creams, ointments, gels), transdermal patches, and other specialized routes.

Segmentation by Application:

a. Hospital Pharmacy: Hospital pharmacies play a crucial role in providing generic drugs within hospital settings. They ensure the availability, safety, and appropriate use of medications for inpatients, outpatients, and healthcare professionals. Hospital pharmacies often manage complex medication regimens and may include specialized units like oncology pharmacies or clinical trial pharmacies.

b. Retail Pharmacy: Retail pharmacies are accessible to the general public and are a common source of generic drugs for individuals with prescriptions. They include chain pharmacies, independent pharmacies, and online pharmacies. Retail pharmacies provide counseling, medication dispensing, and medication management services to patients.

c. Other: This category encompasses applications not covered by hospital or retail pharmacies. It could include specialized pharmacies catering to specific patient populations (e.g., geriatric pharmacies, pediatric pharmacies), clinics providing medication services, long-term care facilities, and other healthcare settings.

Segmentation by Region:

a. North America: The North American region, including the United States and Canada, represents a significant market for generic drugs. Factors such as a well-established healthcare infrastructure, high adoption of generic medications, and a large patient population contribute to the growth of the market in this region.

b. APAC (Asia-Pacific): The Asia-Pacific region, including countries like China, India, Japan, South Korea, and Australia, has a rapidly growing generic drugs market. Factors such as a large population, increasing healthcare expenditure, rising prevalence of chronic diseases, and government initiatives promoting generic drug use contribute to the market's growth in this region.

c. Europe: Europe has a well-developed market for generic drugs, with countries in the European Union (EU) being major contributors. Factors such as government policies encouraging generic drug use, a strong regulatory framework, and cost containment initiatives drive the market's growth in this region.

d. Middle East & Africa: The Middle East and Africa region, including countries like Saudi Arabia, UAE, South Africa, and Nigeria, has a growing market for generic drugs. Factors such as increasing healthcare infrastructure development, rising demand for affordable medications, and a growing focus on reducing healthcare costs contribute to the market's expansion in this region.

Key developments
1. India's Dr. Reddy's Laboratories: Expanding its portfolio of generic drugs, particularly in the United States market.
2. USA's Teva Pharmaceutical Industries: Introducing new generic drug formulations to address healthcare affordability.
3. China's Hengrui Medicine: Increasing investments in research and development of generic drugs for global markets.
4. Israel's Mylan: Launching generic versions of essential medications to improve access to healthcare worldwide.
Key Players

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Teva

Novartis

Viatris

Sun Pharmaceutical

Aspen Pharmacare

Fresenius Kabi

Sanofi

Aurobindo

Lupin

Dr. Reddy's

Apotex

Cipla

ENDO

Stada Arzneimittel

Bausch Health

Hikma

Torrent

Glenmark

Piramal Pharma

Sawai Pharmaceutical

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Drugs Market Size 2019-2030
2.1.2 Generic Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Generic Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Other
2.3 Generic Drugs Market Size by Type
2.3.1 Generic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Generic Drugs Market Size Market Share by Type (2019-2024)
2.4 Generic Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Generic Drugs Market Size by Application
2.5.1 Generic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Generic Drugs Market Size Market Share by Application (2019-2024)
3 Generic Drugs Market Size by Player
3.1 Generic Drugs Market Size Market Share by Players
3.1.1 Global Generic Drugs Revenue by Players (2019-2024)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Generic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Generic Drugs by Regions
4.1 Generic Drugs Market Size by Regions (2019-2024)
4.2 Americas Generic Drugs Market Size Growth (2019-2024)
4.3 APAC Generic Drugs Market Size Growth (2019-2024)
4.4 Europe Generic Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Generic Drugs Market Size Growth (2019-2024)
5 Americas
5.1 Americas Generic Drugs Market Size by Country (2019-2024)
5.2 Americas Generic Drugs Market Size by Type (2019-2024)
5.3 Americas Generic Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Drugs Market Size by Region (2019-2024)
6.2 APAC Generic Drugs Market Size by Type (2019-2024)
6.3 APAC Generic Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Generic Drugs by Country (2019-2024)
7.2 Europe Generic Drugs Market Size by Type (2019-2024)
7.3 Europe Generic Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Generic Drugs by Region (2019-2024)
8.2 Middle East & Africa Generic Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Generic Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Generic Drugs Market Forecast
10.1 Global Generic Drugs Forecast by Regions (2025-2030)
10.1.1 Global Generic Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Generic Drugs Forecast
10.1.3 APAC Generic Drugs Forecast
10.1.4 Europe Generic Drugs Forecast
10.1.5 Middle East & Africa Generic Drugs Forecast
10.2 Americas Generic Drugs Forecast by Country (2025-2030)
10.2.1 United States Generic Drugs Market Forecast
10.2.2 Canada Generic Drugs Market Forecast
10.2.3 Mexico Generic Drugs Market Forecast
10.2.4 Brazil Generic Drugs Market Forecast
10.3 APAC Generic Drugs Forecast by Region (2025-2030)
10.3.1 China Generic Drugs Market Forecast
10.3.2 Japan Generic Drugs Market Forecast
10.3.3 Korea Generic Drugs Market Forecast
10.3.4 Southeast Asia Generic Drugs Market Forecast
10.3.5 India Generic Drugs Market Forecast
10.3.6 Australia Generic Drugs Market Forecast
10.4 Europe Generic Drugs Forecast by Country (2025-2030)
10.4.1 Germany Generic Drugs Market Forecast
10.4.2 France Generic Drugs Market Forecast
10.4.3 UK Generic Drugs Market Forecast
10.4.4 Italy Generic Drugs Market Forecast
10.4.5 Russia Generic Drugs Market Forecast
10.5 Middle East & Africa Generic Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Generic Drugs Market Forecast
10.5.2 South Africa Generic Drugs Market Forecast
10.5.3 Israel Generic Drugs Market Forecast
10.5.4 Turkey Generic Drugs Market Forecast
10.5.5 GCC Countries Generic Drugs Market Forecast
10.6 Global Generic Drugs Forecast by Type (2025-2030)
10.7 Global Generic Drugs Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Drugs Product Offered
11.1.3 Teva Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Generic Drugs Product Offered
11.2.3 Novartis Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Viatris
11.3.1 Viatris Company Information
11.3.2 Viatris Generic Drugs Product Offered
11.3.3 Viatris Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Viatris Main Business Overview
11.3.5 Viatris Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Drugs Product Offered
11.4.3 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen Pharmacare
11.5.1 Aspen Pharmacare Company Information
11.5.2 Aspen Pharmacare Generic Drugs Product Offered
11.5.3 Aspen Pharmacare Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Aspen Pharmacare Main Business Overview
11.5.5 Aspen Pharmacare Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Drugs Product Offered
11.6.3 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Generic Drugs Product Offered
11.7.3 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Aurobindo
11.8.1 Aurobindo Company Information
11.8.2 Aurobindo Generic Drugs Product Offered
11.8.3 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Aurobindo Main Business Overview
11.8.5 Aurobindo Latest Developments
11.9 Lupin
11.9.1 Lupin Company Information
11.9.2 Lupin Generic Drugs Product Offered
11.9.3 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Lupin Main Business Overview
11.9.5 Lupin Latest Developments
11.10 Dr. Reddy's
11.10.1 Dr. Reddy's Company Information
11.10.2 Dr. Reddy's Generic Drugs Product Offered
11.10.3 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Dr. Reddy's Main Business Overview
11.10.5 Dr. Reddy's Latest Developments
11.11 Apotex
11.11.1 Apotex Company Information
11.11.2 Apotex Generic Drugs Product Offered
11.11.3 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Apotex Main Business Overview
11.11.5 Apotex Latest Developments
11.12 Cipla
11.12.1 Cipla Company Information
11.12.2 Cipla Generic Drugs Product Offered
11.12.3 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cipla Main Business Overview
11.12.5 Cipla Latest Developments
11.13 ENDO
11.13.1 ENDO Company Information
11.13.2 ENDO Generic Drugs Product Offered
11.13.3 ENDO Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 ENDO Main Business Overview
11.13.5 ENDO Latest Developments
11.14 Stada Arzneimittel
11.14.1 Stada Arzneimittel Company Information
11.14.2 Stada Arzneimittel Generic Drugs Product Offered
11.14.3 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Stada Arzneimittel Main Business Overview
11.14.5 Stada Arzneimittel Latest Developments
11.15 Bausch Health
11.15.1 Bausch Health Company Information
11.15.2 Bausch Health Generic Drugs Product Offered
11.15.3 Bausch Health Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Bausch Health Main Business Overview
11.15.5 Bausch Health Latest Developments
11.16 Hikma
11.16.1 Hikma Company Information
11.16.2 Hikma Generic Drugs Product Offered
11.16.3 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Hikma Main Business Overview
11.16.5 Hikma Latest Developments
11.17 Torrent
11.17.1 Torrent Company Information
11.17.2 Torrent Generic Drugs Product Offered
11.17.3 Torrent Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Torrent Main Business Overview
11.17.5 Torrent Latest Developments
11.18 Glenmark
11.18.1 Glenmark Company Information
11.18.2 Glenmark Generic Drugs Product Offered
11.18.3 Glenmark Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Glenmark Main Business Overview
11.18.5 Glenmark Latest Developments
11.19 Piramal Pharma
11.19.1 Piramal Pharma Company Information
11.19.2 Piramal Pharma Generic Drugs Product Offered
11.19.3 Piramal Pharma Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Piramal Pharma Main Business Overview
11.19.5 Piramal Pharma Latest Developments
11.20 Sawai Pharmaceutical
11.20.1 Sawai Pharmaceutical Company Information
11.20.2 Sawai Pharmaceutical Generic Drugs Product Offered
11.20.3 Sawai Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Sawai Pharmaceutical Main Business Overview
11.20.5 Sawai Pharmaceutical Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Generic Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of Other
Table 5. Generic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Generic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Generic Drugs Market Size Market Share by Type (2019-2024)
Table 8. Generic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Generic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Generic Drugs Market Size Market Share by Application (2019-2024)
Table 11. Global Generic Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Generic Drugs Revenue Market Share by Player (2019-2024)
Table 13. Generic Drugs Key Players Head office and Products Offered
Table 14. Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Generic Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Generic Drugs Market Size Market Share by Regions (2019-2024)
Table 19. Global Generic Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Generic Drugs Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Generic Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Generic Drugs Market Size Market Share by Country (2019-2024)
Table 23. Americas Generic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Generic Drugs Market Size Market Share by Type (2019-2024)
Table 25. Americas Generic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Generic Drugs Market Size Market Share by Application (2019-2024)
Table 27. APAC Generic Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Generic Drugs Market Size Market Share by Region (2019-2024)
Table 29. APAC Generic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Generic Drugs Market Size Market Share by Type (2019-2024)
Table 31. APAC Generic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Generic Drugs Market Size Market Share by Application (2019-2024)
Table 33. Europe Generic Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Generic Drugs Market Size Market Share by Country (2019-2024)
Table 35. Europe Generic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Generic Drugs Market Size Market Share by Type (2019-2024)
Table 37. Europe Generic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Generic Drugs Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Generic Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Generic Drugs Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Generic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Generic Drugs Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Generic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Generic Drugs Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Generic Drugs
Table 46. Key Market Challenges & Risks of Generic Drugs
Table 47. Key Industry Trends of Generic Drugs
Table 48. Global Generic Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Generic Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Generic Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Generic Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Teva Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 53. Teva Generic Drugs Product Offered
Table 54. Teva Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Teva Main Business
Table 56. Teva Latest Developments
Table 57. Novartis Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 58. Novartis Generic Drugs Product Offered
Table 59. Novartis Main Business
Table 60. Novartis Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Novartis Latest Developments
Table 62. Viatris Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 63. Viatris Generic Drugs Product Offered
Table 64. Viatris Main Business
Table 65. Viatris Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Viatris Latest Developments
Table 67. Sun Pharmaceutical Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 68. Sun Pharmaceutical Generic Drugs Product Offered
Table 69. Sun Pharmaceutical Main Business
Table 70. Sun Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Sun Pharmaceutical Latest Developments
Table 72. Aspen Pharmacare Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 73. Aspen Pharmacare Generic Drugs Product Offered
Table 74. Aspen Pharmacare Main Business
Table 75. Aspen Pharmacare Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Aspen Pharmacare Latest Developments
Table 77. Fresenius Kabi Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 78. Fresenius Kabi Generic Drugs Product Offered
Table 79. Fresenius Kabi Main Business
Table 80. Fresenius Kabi Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Fresenius Kabi Latest Developments
Table 82. Sanofi Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 83. Sanofi Generic Drugs Product Offered
Table 84. Sanofi Main Business
Table 85. Sanofi Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Sanofi Latest Developments
Table 87. Aurobindo Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 88. Aurobindo Generic Drugs Product Offered
Table 89. Aurobindo Main Business
Table 90. Aurobindo Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Aurobindo Latest Developments
Table 92. Lupin Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 93. Lupin Generic Drugs Product Offered
Table 94. Lupin Main Business
Table 95. Lupin Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Lupin Latest Developments
Table 97. Dr. Reddy's Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 98. Dr. Reddy's Generic Drugs Product Offered
Table 99. Dr. Reddy's Main Business
Table 100. Dr. Reddy's Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Dr. Reddy's Latest Developments
Table 102. Apotex Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 103. Apotex Generic Drugs Product Offered
Table 104. Apotex Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Apotex Main Business
Table 106. Apotex Latest Developments
Table 107. Cipla Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 108. Cipla Generic Drugs Product Offered
Table 109. Cipla Main Business
Table 110. Cipla Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Cipla Latest Developments
Table 112. ENDO Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 113. ENDO Generic Drugs Product Offered
Table 114. ENDO Main Business
Table 115. ENDO Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. ENDO Latest Developments
Table 117. Stada Arzneimittel Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 118. Stada Arzneimittel Generic Drugs Product Offered
Table 119. Stada Arzneimittel Main Business
Table 120. Stada Arzneimittel Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Stada Arzneimittel Latest Developments
Table 122. Bausch Health Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 123. Bausch Health Generic Drugs Product Offered
Table 124. Bausch Health Main Business
Table 125. Bausch Health Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Bausch Health Latest Developments
Table 127. Hikma Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 128. Hikma Generic Drugs Product Offered
Table 129. Hikma Main Business
Table 130. Hikma Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Hikma Latest Developments
Table 132. Torrent Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 133. Torrent Generic Drugs Product Offered
Table 134. Torrent Main Business
Table 135. Torrent Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Torrent Latest Developments
Table 137. Glenmark Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 138. Glenmark Generic Drugs Product Offered
Table 139. Glenmark Main Business
Table 140. Glenmark Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Glenmark Latest Developments
Table 142. Piramal Pharma Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 143. Piramal Pharma Generic Drugs Product Offered
Table 144. Piramal Pharma Main Business
Table 145. Piramal Pharma Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Piramal Pharma Latest Developments
Table 147. Sawai Pharmaceutical Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 148. Sawai Pharmaceutical Generic Drugs Product Offered
Table 149. Sawai Pharmaceutical Main Business
Table 150. Sawai Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. Sawai Pharmaceutical Latest Developments

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Nikita Jabrela

Business Development Manager

Interested to schedule a FACE-TO-FACE meeting? Schedule a Call

Trusted Partners

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

Order Placed (21 March, 2025)
Notify To Team (21 March, 2025)
Report updation (22 March, 2025)
Report Quality Check (22 March, 2025)
Report Dispatch (23 March, 2025)

Email
Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Searching...

Global Generic Drugs Market Growth (Status and Outlook) 2024-2030

2024